A structured technical collaboration program connecting biopharmaceutical process development scientists with next-generation purification technologies.
PROGRAM CHAIR
Professor Stefano Menegatti
NC STATE UNIVERSITY | CHROMAGENIX
Shaping GMP-ready purification technologies around your process constraint
If your team is working through unresolved purification constraints in mRNA, lentiviral vectors, viral vector impurity control or recombinant protein HCP clearance, NAVIGATE provides a structured route to discuss the problem and help define what a useful solution would need to prove.
NAVIGATE connects development teams directly to our tunable synthetic ligand development capabilities and expertise to overcome downstream processing bottlenecks.
Share your challenge, help refine product specifications, define your performance requirements and shape your roadmap to a GMP-ready manufacturing solution.
- Early access to ChromaGenix technologies
- Scientist to scientist collaboration with R&D and Applications team
- Guide product specifications to overcome DSP bottlenecks
- Early access to insight, data and application notes
- Peer roundtables with senior manufacturing professionals across four modalities
Through structured Product Focus Sessions and Product Focus Groups, participants help define what future GMP-ready purification tools must demonstrate in real workflows: recovery, impurity clearance, functional preservation, scalability, cleaning compatibility, analytical requirements and process fit.
From Collaboration to GMP-Ready Product
HOW IT WORKS
Focus Areas
Solving The Persistent HCP Challenge in rProtein Purification
HCP Clearance | rProteins
Addressing the escalating complexity of Host Cell Protein removal in high-titer recombinant protein processes. Breaking traditional yield, purity, and complexity trade-offs through next-generation synthetic ligand technology.
Lentivirus Purification
mRNA Purification
Moving Beyond Non-Selective HCP Clearance for Viral Vectors
Impurity Clearance | Viral Vectors
Access new solutions for HCP, DNA and process-debris control to improve AAV or LVV downstream robustness.
Why participate?
Early technical visibility
Review emerging technology direction before release.
Direct product input
Help define the performance thresholds, process conditions, analytical readouts and GMP-readiness expectations that would make a future product useful.
Scientist-led discussion
Engage with ChromaGenix technical teams on the process problem, not a generic sales pitch.
Potential evaluation pathway
Where there is technical fit, discussion may progress toward deeper data review, Product Focus Group participation, prototype evaluation or collaboration.
FAQs
The strongest sessions usually include process development, DSP, analytical, MSAT or CMC stakeholders who understand the current workflow and the evidence required for technical adoption and can work directly with our Applications and R&D scientists.
Useful inputs include molecule or modality, workflow position, feedstream context, impurity burden, current purification approach, analytical readouts, recovery targets, scalability constraints and where the process currently creates the most burden.
Typically we conduct a brief technical qualification session with your choice of either meeting with one of our scientists or completing a questionnaire.
This is to ensure our offering is a good fit for your process challenge. Once assessed we will recommend a framework for ongoing collaboration to support your needs. This could be active development, testing, technical collaboration or a further meeting with a wider team if necessary.
Public content may include approved development summaries and non-confidential development data. Deeper datasets, prototype details, experimental context, applications services and process-specific discussion may require CDA-covered engagement.
NAVIGATE products are in emerging or advanced development-stages unless otherwise stated. The purpose is to make our tunable development pipeline accessible to early adopters experiencing real process constraints using current commercially-available technologies, in order to provide a GMP-ready, scalable solution.
Not always. NAVIGATE is our way to connect with process development scientists to ensure we're providing unique, practical solutions to solve currently unmet needs in downstream processing.
Where the technology, maturity and process need align, the discussion may progress toward prototype evaluation or ongoing collaboration.
Evaluating AAV capture? Discover AvXcelTM
Our serotype-agnostic, alkaline-stable AAV affinity resin with flexible elution properties for higher recovery and preserved viral activity.
Put your downstream challenge into focus
Join NAVIGATE as an early adopter. Test new resins with your own feedstock, access pre-commercial data, and be first to know when products launch.
Complete the form and a member of our team will be in touch shortly.
